Introduction
Enterococci are normal inhabitants of the human and animal gastrointestinal tract.
Although considered as relatively harmless nosocomial pathogens, enterococci have emerged as the third leading cause of serious bloodstream infections (1) . Additionally, they are increasingly found in urinary tract infections, endocarditis, wound infections and abdominal infections. The emergence of infections with enterococci can largely be attributed to their ability to acquire high-level drug resistance through horizontal gene transfer and their multiresistant nature to various classes of antibiotics. In particular Enterococcus faecium has adapted to the abundant antibiotic use in hospitals by acquiring resistance to high dose aminoglycosides, β-lactam antibiotics, and vancomycin (2) (3) (4) . Historically, 80 to 90% of clinical isolates of enterococci were Enterococcus faecalis, whereas E. faecium accounted for 5-10% (5) . Currently, though, proportions of E. faecium isolates among all enterococcal infections is steadily increasing and exceeds 30% (6) .
These E. faecium isolates predominantly belong to a distinct genetic subpopulation, called clonal complex-17 (CC17), that has adapted extremely well to the hospital environment and that has spread world wide (7) . CC17 is characterized by the acquisition of multiple adaptive mechanisms including ampicillin and quinolone resistance and a putative pathogenicity island harboring the esp virulence gene (8) (9) (10) .
The innate immune system provides the fi rst line of defense against invading pathogens by recognizing so called pathogen-associated molecular patterns (PAMPs). PAMPs are essential, conserved microbial patterns that are shared by large groups of pathogens and are not expressed by higher eukaryotes (11, 12) . PAMPs are recognized by pattern recognition receptors, among which the family of Toll-like receptors (TLRs) prominently features. TLRs play an eminent role in the detection of microorganisms and the induction of an adequate immune response (13, 14) . So far, 10 human TLRs have been described. TLR2 has been identifi ed as a receptor that is central to the innate immune response to several Gram-positive bacteria and for cellular signaling by components of Grampositive bacteria such as peptidoglycan, lipoteichoic acid (LTA) and lipoproteins (15) (16) (17) (18) (19) (20) .
TLR4 recognizes lipopolysaccharide (LPS) and is therefore important in the immune
response to Gram-negative bacteria (21, 22) . Another pattern recognition receptor, CD14, is a glycosylphophatidylinositol surface-anchored molecule expressed by many cells.
This receptor lacks an intracellular segment and functions as a coreceptor for numerous bacterial products, including peptidoglycan, LPS, and bacterial lipoproteins, thereby facilitating signaling through other receptors (23) . During Gram-negative infection CD14 28 Chapter 2 plays an important role in the induction of a protective immune response by its capacity to present LPS to the TLR4/MD2 signaling complex (13, 14, (24) (25) (26) (27) 28 ) . CD14 has been shown to be coexpressed and to form a complex with transmembrane TLR2 and to facilitate LTA signaling through TLR2 (23, 29, 30 ), yet, knowledge of the role of this receptor in host defense against Gram-positive bacteria is limited.
Importantly, signaling of all known TLRs except TLR3 relies on the intracellular adaptor MyD88. Additionally, MyD88 serves as the essential adaptor for other IL-1/TLR family members, including the type I IL-1R and IL-18R. Activation of the intracellular pathway through MyD88 results in the activation of NF-κB and expression of proinfl ammatory mediators such as cytokines and chemokines (31, 32) .
Very little is known about host defense mechanisms during infection with E. faecium.
Such knowledge is important considering the increase in antibiotic resistance and clinical relevance of multiresistant E. faecium. Therefore, we here sought to investigate the roles of TLR2, TLR4, CD14 and MyD88 in the immune response to E. faecium using a newly developed model of peritonitis with this opportunistic pathogen.
Materials and Methods

Mice
Specifi c pathogen-free 10-wk-old female wild-type (WT) C57BL/6 mice were purchased from Harlan Sprague-Dawley. Tlr2 gene-defi cient (TLR2 KO), TLR4 KO and MyD88 KO mice, backcrossed to a C57BL/6 background at least six times, were generated as described previously (22, 32, 33) . CD14 KO mice, backcrossed to C57BL/6 background, were obtained from the Jackson Laboratories. All mice were bred in the animal facility of the Academic Medical Center (Amsterdam, the Netherlands). Age-and sex-matched C57BL/6 mice were used as controls in all experiments. The animals were housed in rooms with a controlled temperature and a 12-h light-dark cycle. They were acclimatized for 1 wk before usage, and received standard rodent chow and water ad libitum. The Animal Care and Use Committee of the University of Amsterdam approved all experiments.
Bacterial strain
A vancomycin resistant E. faecium strain, E155, was used in all experiments. This clinical isolate from the Cook County Hospital (Chicago, IL), belongs to CC17. For all experiments, the bacteria were grown overnight on agar sheep blood plates and then grown for ~ 3.5 hours in Todd-Hewitt broth (Difco) to midlogarithmic phase at 37˚C, while shaking. CFU of E. faecium in 200 μl sterile isotonic saline. The inoculum was plated immediately after inoculation on sheep blood agar plates to determine viable counts.
Collection of samples
For comparison of bacterial outgrowth and to examine host responses in the experimental groups, mice were killed at different time points. To set up the E. faecium peritonitis model, mice were sacrifi ced 2, 6, 24 and 48 h after infection. In the other experiments, mice were killed at indicated time points. Mice were anesthetized by inhalation of isofl urane (Abbot, Laboratories)/02 (2%/ 2 liter) and a peritoneal lavage was performed with 5 ml of sterile PBS using a 18-gauge needle; the peritoneal lavage fl uid was collected in sterile polypropylene tubes (Plastipack; BD Biosciences). After collection of peritoneal fl uid, blood was drawn by cardiac puncture, with a sterile syringe, transferred to heparingel vacutainer tubes and immediately placed on ice. Next, the abdomen was opened and the liver, spleen and lungs were harvested.
Determination of bacterial outgrowth
The number of E. faecium CFU was determined in peritoneal lavage fl uid, blood, liver and lung homogenates. To correct for the difference in organ weight, four times the weight (in milligrams) in microliters of sterile saline was added. The organs were homogenized at 4˚C with a tissue homogenizer (Biospect Products), which was carefully cleaned and disinfected with 70% ethanol after each homogenization. Next, serial 10-fold dilutions were made of each sample in sterile saline and 50 μl of each dilution was plated onto blood agar plates. The plates were incubated at 37°C under 5% CO 2 , and CFU were counted after 20 h and corrected for the dilution factor.
Cell counts and differentials
Total cell numbers were counted from each peritoneal lavage sample using a hemocytometer (Beckman Coulter). Differential cell counts were performed on cytospin preparations, stained with a modifi ed Giemsa stain (Diff-Quick; Dade Behring). Peritoneal fl uid supernatant was stored at -20˚C until determination of cytokines.
30
Chapter 2
Histology
Directly after sacrifi ce, lung, liver and spleen were fi xed in 4% formalin, and embedded in paraffi n for routine histology. Sections of 4-μm thickness were stained with H&E. All slides were coded and scored by a pathologist without knowledge of the type of mice or treatment. 
Assays
Preparation of peritoneal macrophages
Peritoneal macrophages from untreated TLR2 KO, TLR4 KO, CD14 KO, MyD88 KO, and WT mice (n = 5-8/strain) were harvested by peritoneal lavage with 5 ml sterile PBS as described (34, 35) . Total cell numbers were counted from each sample using a hemocytometer. hours. Supernatants were collected and stored at -20°C until assayed. Blood was drawn from the same mice and collected in heparin-gel vacutainer tubes, 50 μl/sample was divided in 96-well plates (Greiner). Stimulations were conducted as described for the macrophages.
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Phagocytosis assays
Phagocytosis was evaluated in essence as described previously (34, 37 and neutrophils were labeled using anti-Gr-1-PE (BD Pharmingen), using concentrations as recommended by the manufacturer. Cells were washed with ice-cold FACS buffer after which the degree of phagocytosis of neutrophils and macrophages was determined using the FACSCalibur (BD Biosciences).
Bacterial killing assay
Bacterial killing was determined as described previously (38) . In brief, peritoneal macrophages were harvested from WT, TLR2 KO, MyD88 KO and CD14 KO mice and plated as described above (n=5 per strain). E. faecium was added at a multiplicity of infection of 50 and spun onto cells at 2000 rpm for 5 min, after which plates were placed at 37˚C for 10 min. Each well was then washed 5 times with ice-cold PBS to remove extracellular bacteria. To determine bacterial uptake after 10 min, cells were lysed with sterile dH 2 O and designated as t=0. RPMI 1640 was added to remaining wells and plates were placed at 37˚C for 10 and 60 min after which cells were again washed 5 times with ice-cold PBS and lysed with dH 2 O. Cell lysates were plated on blood agar plates and bacterial counts were enumerated after 16h. Bacterial killing was expressed as the percentage of killed bacteria in relation to t=0.
Human embryonic kidney (HEK) cells
To establish the responsiveness of TLR2 and TLR4, in the presence or absence of CD14, with 10% FCS, 2 mM L-glutamine, penicillin, and streptomycin. Cells were trypsinized and seeded into 96-well plates at a density of 1 x 10 5 cells/well. The cells were stimulated the following day with 10 6 CFU/ml viable E. faecium, LTA (10 μg/ml) or LPS (100 ng/ml).
TLR4 requires MD-2, a small glycosylated protein, to optimally sense LPS. We therefore used a HEK cell line expressing soluble MD2; supernatant of this cell line was used for HEK-TLR4 stimulation. IL-8 release was used as read-out and measured by using a commercially available ELISA (Bio-source International). Cells were stimulated for 5 h and each stimulation was performed in quadruplicate.
Statistical analysis
All data are expressed as mean ± SEM. Difference between groups were analyzed with
Mann-Whitney U test or Kruskal-Wallis analysis with Dunn post test where appropriate.
These analysis were performed using Graph-Pad Prism version 4 (GraphPad Software).
Values of p < 0.05 were considered statistically signifi cant. faecium (n = 5/group) and observed for 48 h. One day after infection 4 of 5 mice infected with 10 10 CFU had died, and 2 mice infected with 10 9 CFU were severely ill; these mice died within the next hours. The other mice from this group were ill, but survived the 48 h.
Results
E. faecium peritonitis mouse model
Mice that were injected with either 10 7 or 10 8 CFU did not show any signs of illness during the entire experiment. After 48 h the surviving mice were sacrifi ced. From the 3 surviving mice that were infected with 10 9 CFU, enterococci were isolated from all cultured organs:
blood, peritoneal lavage fl uid, liver and lungs. From the other mice, enterococci could no longer be cultured.
Insights into the kinetics of the clearance of enterococci and in the accompanying immune response were obtained by infecting two groups of mice with either 10 8 or 10 9 CFU E. faecium and sacrifi cing 5 mice per group 2, 6, 24 (on two occasions) and 48 h after infection. In accordance with our fi rst set of experiments, of mice infected with 33 TLRs in E. faecium peritonitis 10 9 CFU 1 mouse died after 24 h and 2 mice died between 24 en 48 h after enterococcal injection. The remaining mice were severely ill; these mice did not clear the infection and remained bacteremic throughout (Fig. 1) . In contrast, mice infected with 10 8 CFU were able to gradually eliminate the enterococci during this period (Fig. 1) . In these animals, a rapid increase in the number of peritoneal cells was seen; the early increase was mainly caused by a strong infl ux of neutrophils, which peaked 6 h after E. faecium infection (Table I) . After an initial decrease, the number of macrophages increased in peritoneal fl uid from 24 h postinfection onwards (Table I) . Both macrophages and neutrophils were observed with phagocytosed enterococci (data not shown). Peritoneal cells harvested from mice injected with 10 9 CFU were counted and differentiated as well, yet these cells appeared lysed and no reliable conclusions could be drawn from these results. E. were seen in lung and liver that increased in time. In lungs mild pleuritis, interstitial infl ammation and edema were seen. Twenty-four hours after the infection, infl ammation was seen with necrosis and some thrombi in liver (data not shown). Mice received an i.p. injection with E. faecium ( KO mice. These data suggest that the early defense of MyD88 KO mice is impaired at the primary site of infection, which leads to a modestly increased dissemination later on.
To obtain insight into the mechanisms underlying the elevated bacterial loads in the peritoneal cavity of MyD88 KO mice early after infection, we determined the number of leukocytes recruited to the site of infection. At both 2 and 24 h after infection MyD88
KO mice demonstrated a diminished number of neutrophils in their peritoneal lavage fl uid (Fig. 3A , p < 0.01 vs WT mice). This impaired response was accompanied by lower concentrations of the CXC chemokine LIX in the peritoneal cavity, whereas KC and MIP-2 levels did not differ between groups; at 24 h the concentrations of these three chemokines were below the detection limit of the assays in both mouse strains (Fig. 3B-3D) . Similarly, the early (2 h) cytokine response was indistinguishable between MyD88 and WT mice:
TNF-α, IL-6, IL-10 and MCP-1 concentrations did not differ in either peritoneal lavage fl uid or plasma (Table II) . At later time points, the levels of these mediators were either very low or undetectable (data not shown).
Together these data suggest that MyD88 defi ciency results in an impairment of the early immune response to E. faecium peritonitis primarily due to a reduced recruitment of neutrophils to the site of the infection. Mice were i.p. infected with 5 x 10 7 CFU E. faecium and sacrifi ced 2 h thereafter. Data are means ± SEM (n = 7-8 mice/group). 7 CFU E. faecium and killed 2 and 24 h thereafter (6-7 mice/group). Two hours after infection MyD88 KO mice showed higher bacterial loads in peritoneal fl uid and liver.
Twenty-four hours after the infection, bacterial loads were similar in MyD88 KO and WT mice, except for in lungs.
Peritoneal fl uid (A), blood (B), liver (C) and lung (D).
Results are expressed as mean ± SEM. *, p < 0.05.
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E. faecium stimulates peritoneal macrophages via TLR2
To determine the contribution of TLR2, TLR4 and CD14 we assessed the responsiveness of peritoneal macrophages recovered from TLR2, TLR4, CD14 KO and WT mice toward E. faecium, and compared these with the responsiveness of peritoneal macrophages recovered from MyD88 KO mice (Fig. 4) . In contrast to the modest in vivo cytokine response to E. faecium, WT macrophages demonstrated strong cytokine release upon stimulation with this bacterium in vitro as shown for TNF-α. MyD88 KO, TLR2 KO and CD14 KO macrophages all showed a strongly reduced TNF-α release upon incubation with E. faecium (Fig. 4) . TLR4 KO macrophages tended to release less TNF-α, but the difference with WT cells was not signifi cant. Additionally, we performed stimulations on whole blood drawn from the aforementioned mice. Comparable results were found for these blood cell stimulations (data not shown). In control experiments and as expected, TLR2 KO macrophages responded normally to LPS but not to LTA, whereas TLR4 KO macrophages responded normally to LTA but not to LPS (data not shown). 
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TLR2 defi ciency results in an impaired early immune response to E. faecium
To further investigate the in vivo role of TLR2 and CD14, TLR2KO and CD14KO mice were infected i.p. with 8x10 7 CFU E. faecium. In accordance to the MyD88 KO mice, TLR2 KO mice displayed a diminished early host response when compared with WT mice. At 2 h after infection, TLR2 KO mice had more E. faecium at the primary site of infection (peritoneal lavage fl uid) (Fig. 6A , p < 0.05 vs WT mice); no differences in bacterial loads were seen in other organs. Furthermore, at later time points no differences in bacterial loads were detected in any body site. As was seen in MyD88 KO mice, TLR2 KO mice showed a diminished peritoneal neutrophil infl ux during the entire experiment (Fig. 7A, p < 0.01 vs WT mice). This reduced neutrophil recruitment was accompanied by lower LIX and KC levels in peritoneal fl uid 2 h after the infection, whereas MIP-2 levels were not different between the two mouse strains. Slightly diminished IL-6, IL-10 and MCP-1 levels were seen in TLR2 KO mice 2 h after the infection (signifi cantly so for plasma IL-6
and MCP-1, and peritoneal fl uid IL-10, Table III ). In contrast to the in vitro studies described above, TNF-α levels were similar in both mouse strains. Twenty-four hours after the infection, the levels of these mediators were either very low or undetectable (data not shown Data are means ± SEM. *, p < 0.05.
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No role for MyD88 or TLR2 in phagocytosis or killing of E. faecium
In contrast to the reduced antibacterial defense in MyD88 and TLR2 KO mice, as described above, MyD88 and/or TLR2, as well as CD14, did not seem to contribute to phagocytosis and/or killing of E. faecium. As shown in Fig. 8 
Discussion
Enterococci are increasingly causing nosocomial infections worldwide, which is mainly attributed to a rise in multiresistant E. faecium strains, specifi cally adapted to the hospital environment en belonging to CC17 (4, 5) . Especially severely ill, immunocompromised patients are vulnerable to infections with enterococci. In contrast, in healthy human individuals, E. faecium only very rarely causes infections. Knowledge of how the intact innate immune system deals with this bacterium is highly limited. We here investigated the interaction between the host immune system and E. faecium focusing on the role of members of the TLR family. As such, the primary objective of the current studies was to answer the question whether intact TLR signaling is the reason why a healthy host is not susceptible to E. faecium infection. Using a newly developed mouse model of E.
faecium peritonitis, we show that MyD88, the common adaptor protein for TLR signaling, contributes to an effective clearance of E. faecium during the early phase after infection, most likely by stimulating the recruitment of neutrophils to the primary site of infection.
The protective effect of MyD88 appeared to be mediated at least in part by TLR2, because defi ciency of this receptor resulted in a similar, albeit less strong phenotype early after i.p.
infection with E. faecium, characterized by an initially higher bacterial load in peritoneal fl uid and a diminished neutrophil infl ux. We could not detect a role for either TLR4 or CD14 in host defense against E. faecium peritonitis. Our data are the fi rst to investigate the role of TLRs in the immune response to this emerging pathogen. faecium peritonitis was not accompanied by signifi cant organ damage as indicated by histopathology of lung, liver and spleen and the plasma levels of ASAT, ALAT and creatinin.
Of note, we specifi cally chose to validate the model in healthy WT mice in order to allow subsequent studies in mice lacking components of the innate immune response. In this regard, the absence of mortality and distant organ injury is in line with the fact that the intact immune system can mount an effective response against this intrinsically modestly virulent microorganism.
TLRs are regarded the major molecular mechanism by which the host recognizes invading microorganisms (21, 41, 42 Haemophilus infl uenzae (27) . Moreover, MyD88 KO demonstrated a reduced host defense against systemic infection with either S. aureus (18) or Listeria monocytogenes (47), but were protected from severe polymicrobial peritonitis (48) . Together these data indicate that although MyD88 is essential for the recognition of a variety of pathogens, its role in the host response in vivo may vary, presumably at least in part depending on the microorganism, the localization, and the severity of the infection.
There is abundant evidence from in vitro observations that TLR2 is the predominant receptor signaling the presence of cell wall components of Gram-positive bacteria, such as peptidoglycan and LTA (15, 16, 49, 50) . In accordance, we found that TLR2 is important for cellular responsiveness toward E. faecium in vitro. Indeed, transfection of TLR2 into HEK cells rendered these cells responsive to E. faecium, whereas TLR2 defi ciency was associated with a loss of responsiveness of macrophages to this bacterium. In addition,
we demonstrated that TLR2 is involved in the early immune response to E. faecium in Twenty-four hours after the induction of the infection, these authors did not see any difference in enterococcal load in kidneys from TLR2 KO compared with WT mice, neither did they fi nd any differences on histological examination. The infl ammatory response was not discussed in this study. Differences in the bacterial strain and/or the route and localization of infection may account for the fact that we did detect a role for TLR2 in the response to infection with enterococci in vivo.
The pattern recognition receptor CD14 is well known to facilitate LPS signaling through TLR4 and LTA signaling through TLR2 (23, 30) . CD14 has been shown to be coexpressed and to form a complex with transmembrane TLR2 (29) . We identifi ed an important role for CD14 in the activation of TLR2 by E. faecium in vitro: HEK cells transfected with both CD14 and TLR2 were much more responsive to E. faecium than HEK cells transfected with TLR2 alone, whereas both CD14 KO and TLR2 KO macrophages were markedly less responsive to E. faecium than WT macrophages. Nonetheless, in our in vivo studies, CD14 did not play a detectable role in E. faecium infection: we did not fi nd any difference in enterococcal clearance, neutrophil recruitment, or cytokine/chemokine responses between CD14 KO and WT mice. The apparent discrepancy between our in vitro and in vivo results on the role of CD14 suggest that other components of the immune system not present in our in vitro systems may compensate for the absence of CD14. CD14 is considered to contribute to an antibacterial response during Gram-negative infection by virtue of its capacity to present LPS to the TLR4/MD2 signaling complex (13, 14) . In Gram-positive infections 
